Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 250-256

  Maurer, Margarita ^a   Komina, Oxana ^a   Wȩsierska Ga̧dek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; CDK; Cell cycle arrest; p53 tumor suppressor; Pharmacological CDK inhibitors; Serum starvation

Indexed keywords

HYDROXYUREA; ROSCOVITINE;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL POPULATION; CELL SYNCHRONIZATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; HUMAN; HUMAN CELL; TREATMENT OUTCOME;

EID: 69149107714     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04717.x     Document Type: Conference Paper

References (15)

1. Nurse, P. 2002. Cyclin dependent kinases and cell cycle control (Nobel lecture). Chembiochem 3 : 596 603.
2. Blagosklonny, M. V. A. B. Pardee. 2001. Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res. 61 : 4301 4305.
3. Meijer, L., A. Borgne, O. Mulner, et al. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243 : 527 536.
4. De Azevedo, W.F., S. Leclerc, L. Meijer, et al. 1997. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 243 : 518 526.
5. Janicke, R.U., M.L. Sprengart, M.R. Wati A.G. Porter. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273 : 9357 9360.
6. Wojciechowski, J., M. Horky, M. Gueorguieva J. Wesierska-Gadek. 2003. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int. J. Cancer 106 : 486 495.
7. Wesierska-Gadek, J., T. Schreiner, M. Maurer, et al. 2007. Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine. Cell. Mol. Biol. Lett. 12 : 280 293.
8. Wesierska-Gadek, J., M. Gueorguieva, M.P. Kramer, et al. 2007. A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein. J. Cell. Biochem. 102 : 1405 1419.
9. Wesierska-Gadek, J., M. Gueorguieva M. Horky. 2005. Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells. Mol. Cancer Ther. 4 : 113 124.
10. Wesierska-Gadek, J. G. Schmid. 2000. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint. J. Cell. Biochem. 80 : 85 103.
11. Vindelov, L.L., I.J. Christensen N.I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3 : 323 327.
12. Wesierska-Gadek, J., M.L. Schmitz C. Ranftler. 2007. Roscovitine- activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells. J. Cell. Biochem. 100 : 865 874.
13. David-Pfeuty, T. 1999. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells. Oncogene 18 : 7409 7422.
14. Alessi, F., S. Quarta, M. Savio, et al. 1998. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell. Res. 245 : 8 18.
15. Wesierska-Gadek, J., M. Gueorguieva M. Horky. 2003. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin. Pol. J. Pharmacol. 55 : 895 902.